Patent · US Active

Diagnostic method for disorders using copeptin

US7807397B2 · kind B2 · utility

19Cited by

0References

2Claims

0Family size

Assignee

B.R.A.H.M.S GMBH · DE

Inventors

Andreas Bergmann · Berlin, DE
Joachim Struck · Berlin, DE

Key dates

Filing date	Aug 19, 2005
Grant date	Oct 5, 2010
Priority date	—
Expiry date	Jul 1, 2026

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY10S930/15
WIPO fieldMeasurement
WIPO sectorInstruments

Abstract

The use of copeptin as diagnostic marker for the determination of the release of vasopressin, especially in connection with disorders associated with non-physiological alterations of vasopressin release from the neurohypophysis, especially for detection and early detection, diagnosing and monitoring of the course of cardiovascular diseases, renal and pulmonary diseases as well as shock, including septic shock, sepsis and diseases/disorders of the central nervous system and neurodegenerative diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.